Skip to main content
Tuesday
November 05, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
TUESDAY,
NOVEMBER 05, 2024
Pfizer-BioNTech vaccine
Coronavirus chronicle
Pfizer booster study lifts mood over Omicron variant
Coronavirus chronicle
Study suggests Pfizer Covid-19 vaccine may only partially protect against Omicron
Covid-19 in Bangladesh
25 lakh more Pfizer doses to arrive Monday
Covid-19 in Bangladesh
Bangladesh to get 89 lakh more doses of Pfizer, Moderna vaccines
Coronavirus chronicle
Full US approval for Pfizer vaccine expected by early September: Report
Covid-19 in Bangladesh
Pfizer says third dose of Covid-19 vaccine boosts protection against Delta variant
Coronavirus chronicle
Politics, health collided in Taiwan's tortured BioNTech vaccine talks
Covid-19 in Bangladesh
1.5cr Pfizer, Sinopharm, Seram vaccines arriving in August
Coronavirus chronicle
UK approves Pfizer jab for use in 12-15-year-olds
World+Biz
Fully vaccinated adults 94% less likely to be hospitalised with covid: Study
Coronavirus chronicle
South African variant can 'break through' Pfizer vaccine, Israeli study says
Coronavirus chronicle
Pfizer, Moderna Covid-19 vaccines highly effective after first shot in real-world use, US study shows
Analysis
What J&J's authorized Covid-19 shot means for the US vaccination campaign
Show More